All In Biotech

Drug Trial Radar · NCT01733459

Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)

The Role of DLBS3233 in the Management of Polycystic Ovary Syndrome (PCOS)

Last checked: Nov 19, 2026Latest source record: Jul 26, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 124 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

124

Actual

Start

Mar 2013

Primary completion

Apr 2018

Study completion Jun 2018

Sponsor

Lead sponsor
Dexa Medica GroupIndustry
Sponsor type
Industry
First posted
Nov 27, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
Female only, from 18 years, up to 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a 2-arm, randomized, double-blind, double-dummy, and controlled clinical study, with 6 months of treatment to evaluate the clinical and metabolic efficacy of DLBS3233 in improving reproductive parameters and to evaluate the safety of DLBS3233 in women with polycystic ovary syndrome compared with metformin, as an active control.

Conditions

  • Polycystic Ovary Syndrome (PCOS)

Interventions

  • DLBS3233Drug

    1 DLBS3233 capsule 100 mg once daily for 6 months

  • Metformin XRDrug

    1 Metformin XR caplet 750 mg twice daily for 6 months

  • Placebo caplet of Metformin XRDrug

    1 placebo caplet of Metformin XR twice daily for 6 months

  • Placebo capsule of DLBS3233Drug

    1 placebo capsule of DLBS3233 once daily for 6 months

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. HOMA-IR reductionTime frame: 6 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Indonesia, dr. Cipto Mangunkusumo Hospital

    Jakarta, Indonesia

  • Department of Obstetrics and Gynecology, Faculty of Medicine, University of Padjadjaran, Hasan Sadikin Hospital

    Bandung, West Java, Indonesia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.